Company intelligence / Profile preview
BLIS Technologies
Dunedin, Otago, New Zealandblis.co.nz ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
BLIS Technologies has developed proprietary oral probiotic strains with demonstrated efficacy in supporting oral cavity health. Their lead strain, Streptococcus salivarius K12 (BLIS K12), has received GRAS status from the US FDA. Clinical trials have shown benefits for oral hygiene and prevention of certain infections. The company’s products are sold globally in various forms including lozenges and powders[1][3].
- Therapeutic areas
- DermatologyImmunologyInfectious DiseasesOther
- Modalities
- Live biotherapeutic product therapyMicrobial therapy
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Probi AB – distribution partnership for North America[5]Wilson Consumer Products Limited – sales/distribution partnership in New Zealand[4]Emma Lewisham – licensing agreement for cosmetic facial serum containing live probiotics [4]
Beyond the preview
Go deeper on BLIS Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BLIS Technologies.